Speeding up the translation from bench to bedside
Objective:
Improve the translational approach in research to increase the number of new treatments and prevention strategies that will become available in health care for OA patients.
Task 2.1: Technical and economic hurdles associated with the establishment and implementation of translational research models (crossing the Valley of Death).
Task 2.2: Guidelines for data collection, sampling, phenotyping, endotyping and clinical trial designs for companies bringing products targeting OA to the market to avoid common repeated failures in phase 2 and 3 clinical trials.
Task 2.3: Identification of the major challenges associated with translation from preclinical models to humans without intermediate translational models.
Task 2.4: European Consensus on Chronic Disease Self-Management Program CDSMP program for OA prevention.
Deliverables
On the 28th of January 2026, at 3pm CET, we had the WG2 Monthly Meeting, that took place online.
During the meeting we discussed the progress of the WG2 work that is being developed. One of the manuscripts that was being prepared is now submitted for publication, another 2 are being revised and completed by authors and others are still in the drafting stage. The Podcast series is being prepared to be released in the coming months. The new call for Short Term Scientific Missions remains open until the 28th of February. A flyer for OA patients is also being prepared.